OR WAIT null SECS
Jill Murphy is Editor of Pharmaceutical Technology.
April 25, 2023
Aspect Biosystems and Novo Nordisk A/S have announced a collaboration, development, and license agreement to develop bioprinted tissue therapeutics.
April 18, 2023
Jaeger notes that the program is focused on addressing specific scientific questions that will produce immediate impacts on how CDER and FDA make drug approval decisions.
April 12, 2023
The decision was issued in a joint statement by the FDA Commissioner and Chief Scientist, and effective on April 11.
The BalanCD CHO media portfolio is designed to ensure maximized growth, viability, and productivity of CHO cell lines.
April 04, 2023
Lon Johnson, VP of Sales and Marketing at Colbert Packaging Corporation, discusses the latest drug packaging updates and how companies can become more sustainable with Pharmaceutical Technology editor Jill Murphy.
April 03, 2023